[The production of tachycardiac arrhythmia through extrasystoles. Mechanism and therapy].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D005117:Cardiac Complexes, Premature / Q000150:complications* / Q000188:drug therapy; D004562:Electrocardiography; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000209:etiology*
D000889:Anti-Arrhythmia Agents; D009921:Metaproterenol; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol
Auslösung tachykarder Arrhythmien durch extrasystolen. Mechanismus und Therapie.